Skip to main content
Toggle navigation
Search
Home
Icon Legend
Food/Drinks Available
CE's Available
Reception
Pre-registration Required
Livestreaming
Recorded Session
Back
Tweet this
Tehilla Blinder
Research Assistant
Splisense, Israel
Poster(s):
(615) Antisense Oligonucleotide-Based Drug Development for Cystic Fibrosis Patients Carrying the 2789+5 G-to-A Splicing Mutation
Thursday, November 3, 2022
12:45 PM – 1:25 PM
ET
(619) Antisense Oligonucleotide Splicing Modulation as a Novel Cystic Fibrosis Therapeutic Approach for the W1282X Nonsense Mutation
Thursday, November 3, 2022
12:45 PM – 1:25 PM
ET
(620) Antisense Oligonucleotide Splicing Modulation as a Novel Cystic Fibrosis Therapeutic Approach for the N1303K Nonsense Mutation
Thursday, November 3, 2022
12:00 PM – 12:40 PM
ET
